Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry
about
Rauwolfia in the Treatment of HypertensionSLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholineNeurofunctional imaging of β-cell dynamicsTetrabenazine: Spotlight on Drug Review.Monoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesImmunomodulatory Effects Mediated by DopamineImaging pancreatic islet cells by positron emission tomographyWhat Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoniMonoamine transporter inhibitors and substrates as treatments for stimulant abuseThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Resting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivoA new VGLUT-specific potent inhibitor: pharmacophore of Brilliant YellowThe vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2)Presynaptic effects of levodopa and their possible role in dyskinesia.Recent progress of imaging agents for Parkinson's disease.Monoamine transporters: vulnerable and vital doorkeepers.Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep.Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestryA Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's DiseaseInfection of human enteroendocrine cells with Chlamydia trachomatis: a possible model for pathogenesis in irritable bowel syndrome.Serotonin and molecular neuroimaging in humans using PET.Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?PET radioligands for the vesicular transporters for monoamines and acetylcholine.Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood DisorderRole of clathrin in dense core vesicle biogenesis.Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine.T lymphocytes possess the machinery for 5-HT synthesis, storage, degradation and release.Chromogranin A and vesicular monoamine transporter 2 immunolocalization in protein bodies of human locus coeruleus neurons.Zingerone activates VMAT2 during MPP(+) -induced Cell Death.Tardive dyskinesia: motor system impairments, cognition and everyday functioning.Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury.Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.Positive and balancing selection on gene associated with psychiatric disorders and human-unique personality traits
P2860
Q26771935-38D831F7-F774-4ECD-94B3-D52FC77CAFAFQ26823246-FDB4106A-324A-49BD-B646-1173683849A3Q26829645-EECD3064-EFB1-44DE-B4CE-8CDA15860D1FQ27692599-1DFE1E94-E596-4EEC-9064-C84E220C720FQ28066691-5D63F4D8-A179-4EE1-A32E-3FE3CD0351C9Q28071580-2CBBF837-DC5E-41DF-804C-E69A007A0AB5Q28075496-FDE5B1DD-D2EC-40CA-A96A-FB8CDE21B88CQ28078271-73A9C8C2-F195-415C-ABE7-6E08B1D1C45AQ28542999-85903A9A-024E-482D-9207-FDBC88E19945Q30413718-B6955617-C2C9-4BD5-947F-F4E2FE39A9DAQ30486743-61390E2A-C9CD-4E03-93A0-5F2AAC04CFFBQ30530379-86D2CE40-FCEF-4905-A474-6CD472119D43Q33630896-9AD248AA-27F9-4859-AB46-474DC59778ACQ33854736-937D096B-0592-42F6-BE02-EF63F227AB06Q34823681-EDCD5F03-2B21-412D-B41C-F88C3B345ECCQ35040280-8A40E5C5-E35F-4699-9797-6B23AEFAF04EQ35595426-574EF099-AAD5-4474-97F5-FD0204800A79Q35877150-D4754FA9-E639-4FCF-9815-3FD97658986CQ36915707-C6B2939F-15D6-4136-8430-8EADEBC49B69Q36976562-A224F763-69E6-427B-974D-DD624173C70DQ37137794-E21617BE-78A6-4A33-AB37-896B31C9B603Q37583405-3945BBF2-656B-4088-9E5A-269B40718790Q37850303-759889C8-AB1A-4803-B73C-84E83A2D936BQ37938794-EE7670A1-D103-4621-AED4-155048F58062Q38134724-97FD632B-612D-4087-86DA-EB134E945302Q38166971-C9F2245B-90AB-44F3-B154-29818B7445C2Q38609330-C72F3D8B-CEED-4079-B35C-83F2AC41D0ABQ38621517-C479EC98-822D-4F53-BAF7-86A3EEA7360FQ38926644-DA0DE359-FC66-4F36-81A3-857A53AA5373Q38966221-60376785-5318-406A-A24B-D9988493B5C7Q39164389-E40C8DD3-96AD-4930-81B2-25C561A0254DQ39269198-BBFD05BC-5F2C-4639-8114-9C43E783A235Q41433801-B6FD0D1B-AA52-44A3-BE0D-0E34594B047AQ45203790-6E296EEB-1C52-456B-AD8E-A3BBBD07DBCFQ46683287-B0AFB908-59EA-47ED-BB36-7D7CC01D13CEQ47628451-BB487244-D233-422E-BB13-723626228AACQ48433008-5783FEA9-3297-460B-A50E-4CDD229F3F37Q48939200-F7AD3943-C206-43F9-AFF9-C0FB3938F1D0Q49490658-8B03A352-8E50-4631-AE37-D620B617FA77Q57132733-964D59F4-2B81-41DE-AE9C-88B079BC4B17
P2860
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@ast
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@en
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@nl
type
label
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@ast
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@en
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@nl
prefLabel
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@ast
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@en
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@nl
P2860
P3181
P356
P1476
Vesicular monoamine transporte ...... ology, and medicinal chemistry
@en
P2093
Kandatege Wimalasena
P2860
P304
P3181
P356
10.1002/MED.20187
P407
P577
2011-07-01T00:00:00Z